Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/4/2026 | 8,921 | 0.1% | 11,558 | 12/31/2025 |
| 2025 Q3 | 10/24/2025 | 6,560 | 0.1% | 11,667 | 9/30/2025 |
| 2025 Q2 | 7/25/2025 | 4,689 | 0.1% | 8,931 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 5,728 | 0.1% | 9,031 | 3/31/2025 |
| 2024 Q4 | 2/5/2025 | 6,426 | 0.1% | 9,021 | 12/31/2024 |
| 2024 Q3 | 10/29/2024 | 9,478 | 0.2% | 9,016 | 9/30/2024 |
| 2024 Q2 | 8/2/2024 | 9,609 | 0.2% | 9,142 | 6/30/2024 |
| 2024 Q1 | 5/3/2024 | 8,644 | 0.2% | 8,981 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 10,271 | 0.2% | 11,694 | 12/31/2023 |
| 2023 Q3 | 10/27/2023 | 16,111 | 0.2% | 19,577 | 9/30/2023 |
| 2023 Q2 | 7/26/2023 | 17,790 | 0.2% | 24,759 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 25,230 | 0.3% | 30,706 | 3/31/2023 |
| 2022 Q4 | 1/26/2023 | 22,498 | 0.3% | 31,183 | 12/31/2022 |
| 2022 Q3 | 11/2/2022 | 20,897 | 0.3% | 30,335 | 9/30/2022 |
| 2022 Q2 | 7/25/2022 | 18,819 | 0.3% | 31,835 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 15,469 | 0.2% | 22,148 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 14,113 | 0.2% | 22,348 | 12/31/2021 |
| 2021 Q3 | 10/19/2021 | 13,598 | 0.2% | 22,470 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 13,137 | 0.1% | 23,521 | 6/30/2021 |
| 2021 Q1 | 4/20/2021 | 15,518 | 0.2% | 32,797 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 15,804 | 0.2% | 32,713 | 12/31/2020 |
| 2020 Q3 | 11/3/2020 | 20,690 | 0.3% | 36,961 | 9/30/2020 |
| 2020 Q2 | 7/21/2020 | 24,645 | 0.4% | 39,517 | 6/30/2020 |
| 2020 Q1 | 4/20/2020 | 22,492 | 0.4% | 46,062 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 6,824 | 0.1% | 18,175 | 12/31/2019 |
| 2014 Q1 | 5/16/2014 | 4,222 | 0.1% | 14,059 | 3/31/2014 |
| 2013 Q4 | 2/13/2014 | 3,815 | 0.1% | 13,859 | 12/31/2013 |